Add to ORKGRecombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow-up of papillary and follicular thyroid cancer. Its clinical ef®ciency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism. European Journal of Endocrinology 143 557±56
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
ABSTRACT Objective To compare the short- and long-term outcomes of adjuvant therapy with radioacti...
Recombinant human TSH (rhTSH) is known to stimulate 131I uptake and thyroglobulin (Tg) release from ...
Traditionally, withdrawal of thyroid hormone to increase serum levels of thyroid-stimulating hormone...
BACKGROUND: Periodic evaluation of serum thyroglobulin (Tg) and whole body 131I imaging ( 131I-WBS) ...
The purpose of this work was to gain clinical experience with and to identify the optimal conditions...
The clinical benefits of recombinant human thyroid-stimulating hormone (rhTSH; Thyrogen (R), Genzyme...
Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after...
Ann Gramza1, Kathryn G Schuff21Division of Medical Oncology, Oregon Health and Science University, P...
Abstract The published studies confirming the safety and efficacy of rhTSH for diagnostic purposes h...
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of t...
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (...
Introduction: Radioiodine (RAI) therapy for treatment of differentiated thyroid cancer (DTC) require...
Recent studies have confirmed that radioactive iodine therapy after recombinant human TSH (rhTSH) st...
Background: this study was designed to compare the long-term survival outcomes of patients prepared ...
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
ABSTRACT Objective To compare the short- and long-term outcomes of adjuvant therapy with radioacti...
Recombinant human TSH (rhTSH) is known to stimulate 131I uptake and thyroglobulin (Tg) release from ...
Traditionally, withdrawal of thyroid hormone to increase serum levels of thyroid-stimulating hormone...
BACKGROUND: Periodic evaluation of serum thyroglobulin (Tg) and whole body 131I imaging ( 131I-WBS) ...
The purpose of this work was to gain clinical experience with and to identify the optimal conditions...
The clinical benefits of recombinant human thyroid-stimulating hormone (rhTSH; Thyrogen (R), Genzyme...
Traditionally, the immediate treatment of patients with differentiated thyroid carcinoma (DTC) after...
Ann Gramza1, Kathryn G Schuff21Division of Medical Oncology, Oregon Health and Science University, P...
Abstract The published studies confirming the safety and efficacy of rhTSH for diagnostic purposes h...
Introduction. Recombinant human thyroid stimulating hormone (rhTSH) is approved for preparation of t...
The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (...
Introduction: Radioiodine (RAI) therapy for treatment of differentiated thyroid cancer (DTC) require...
Recent studies have confirmed that radioactive iodine therapy after recombinant human TSH (rhTSH) st...
Background: this study was designed to compare the long-term survival outcomes of patients prepared ...
Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating h...
ABSTRACT Objective To compare the short- and long-term outcomes of adjuvant therapy with radioacti...
Recombinant human TSH (rhTSH) is known to stimulate 131I uptake and thyroglobulin (Tg) release from ...